Cargando…
Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease
BACKGROUND: In patients with end‐stage renal disease (ESRD) undergoing hemodialysis, cardiovascular diseases, and in particular chronic heart failure are the leading causes of morbidity and mortality. Nevertheless, few data are available about the impact of fluid optimization on echocardiographic pa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545678/ https://www.ncbi.nlm.nih.gov/pubmed/35416387 http://dx.doi.org/10.1111/hdi.13019 |
_version_ | 1784804873061007360 |
---|---|
author | Ursi, Raffaella Pesce, Francesco Albanese, Miriam Pavone, Vittoria Grande, Dario Ciccone, Marco M. Iacoviello, Massimo |
author_facet | Ursi, Raffaella Pesce, Francesco Albanese, Miriam Pavone, Vittoria Grande, Dario Ciccone, Marco M. Iacoviello, Massimo |
author_sort | Ursi, Raffaella |
collection | PubMed |
description | BACKGROUND: In patients with end‐stage renal disease (ESRD) undergoing hemodialysis, cardiovascular diseases, and in particular chronic heart failure are the leading causes of morbidity and mortality. Nevertheless, few data are available about the impact of fluid optimization on echocardiographic parameters of cardiac function in patients with ESRD. METHODS AND RESULTS: In five patients with ESRD undergoing hemodialysis who had developed nonischemic dilated cardiomyopathy, an optimal fluid volume management based on a strict bioelectrical impedance analysis‐assisted dry weight target and dietary sodium and water restriction led to left ventricular reverse remodeling and improvement in hemodynamic parameters. The reverse remodeling further improved after kidney transplantation. CONCLUSIONS: This case series supports the possible beneficial effect of volume status optimization on cardiac function and the potential reversibility of cardiac dysfunction after kidney transplantation. |
format | Online Article Text |
id | pubmed-9545678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95456782022-10-14 Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease Ursi, Raffaella Pesce, Francesco Albanese, Miriam Pavone, Vittoria Grande, Dario Ciccone, Marco M. Iacoviello, Massimo Hemodial Int Original Articles BACKGROUND: In patients with end‐stage renal disease (ESRD) undergoing hemodialysis, cardiovascular diseases, and in particular chronic heart failure are the leading causes of morbidity and mortality. Nevertheless, few data are available about the impact of fluid optimization on echocardiographic parameters of cardiac function in patients with ESRD. METHODS AND RESULTS: In five patients with ESRD undergoing hemodialysis who had developed nonischemic dilated cardiomyopathy, an optimal fluid volume management based on a strict bioelectrical impedance analysis‐assisted dry weight target and dietary sodium and water restriction led to left ventricular reverse remodeling and improvement in hemodynamic parameters. The reverse remodeling further improved after kidney transplantation. CONCLUSIONS: This case series supports the possible beneficial effect of volume status optimization on cardiac function and the potential reversibility of cardiac dysfunction after kidney transplantation. John Wiley & Sons, Inc. 2022-04-13 2022-07 /pmc/articles/PMC9545678/ /pubmed/35416387 http://dx.doi.org/10.1111/hdi.13019 Text en © 2022 The Authors. Hemodialysis International published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ursi, Raffaella Pesce, Francesco Albanese, Miriam Pavone, Vittoria Grande, Dario Ciccone, Marco M. Iacoviello, Massimo Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title | Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title_full | Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title_fullStr | Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title_full_unstemmed | Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title_short | Reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
title_sort | reverse cardiac remodeling after fluid balance optimization in patients with end‐stage renal disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545678/ https://www.ncbi.nlm.nih.gov/pubmed/35416387 http://dx.doi.org/10.1111/hdi.13019 |
work_keys_str_mv | AT ursiraffaella reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT pescefrancesco reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT albanesemiriam reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT pavonevittoria reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT grandedario reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT cicconemarcom reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease AT iacoviellomassimo reversecardiacremodelingafterfluidbalanceoptimizationinpatientswithendstagerenaldisease |